SUPN

55.13

2.42% -1.37

Dopo l'orario di chiusura: 56.19 1.06 +1.92%

Supernus Pharmaceuticals Inc (SUPN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SUPN Giù? Forum Previsione

Precedente Chiudi:

$56.50

Aprire:

$56.33

Volume 24 ore:

904.19K

Relative Volume:

1.08

Capitalizzazione di mercato:

$3.09B

Reddito:

$665.13M

Utile/perdita netta:

$64.50M

Rapporto P/E:

48.18

EPS:

1.1442

Flusso di cassa netto:

$185.87M

1 W Prestazione:

+4.35%

1M Prestazione:

+15.36%

6M Prestazione:

+69.74%

1 anno Prestazione:

+61.81%

Intervallo 1D:

$54.21

$57.33

Intervallo di 1 settimana:

$51.84

$57.65

Portata 52W:

$29.16

$57.65

Supernus Pharmaceuticals Inc Stock (SUPN) Company Profile

Nome

Supernus Pharmaceuticals Inc

Settore

Healthcare (1135)

Industria

Drug Manufacturers - Specialty & Generic (85)

Telefono

301-838-2500

Indirizzo

9715 KEY WEST AVENUE, ROCKVILLE, MD

Dipendente

674

Cinguettio

@Supernus_Pharma

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

SUPN's Discussions on Twitter

Confronta SUPN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SUPN Supernus Pharmaceuticals Inc	55.13	3.17B	665.13M	64.50M	185.87M	1.1442
ZTS Zoetis Inc	144.09	63.86B	9.39B	2.62B	2.22B	5.8121
TAK Takeda Pharmaceutical Co Adr	13.44	41.80B	29.96B	957.25M	4.77B	0.2956
HLN Haleon Plc Adr	9.27	40.88B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	20.48	22.98B	16.70B	-157.13M	1.19B	-0.1446
UTHR United Therapeutics Corp	445.43	19.53B	3.08B	1.24B	1.07B	25.61

Supernus Pharmaceuticals Inc Stock (SUPN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-09	Aggiornamento	Piper Sandler	Neutral → Overweight
2025-07-30	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2025-02-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2025-01-06	Iniziato	Cantor Fitzgerald	Overweight
2024-09-11	Downgrade	Piper Sandler	Overweight → Neutral
2023-01-03	Ripresa	Jefferies	Buy
2021-12-01	Ripresa	Jefferies	Buy
2021-04-13	Aggiornamento	Jefferies	Hold → Buy
2020-06-16	Aggiornamento	Piper Sandler	Neutral → Overweight
2020-06-15	Ripresa	Jefferies	Hold
2019-11-08	Downgrade	Berenberg	Buy → Hold
2019-11-07	Downgrade	Stifel	Buy → Hold
2019-11-06	Downgrade	Jefferies	Buy → Hold
2018-11-12	Reiterato	B. Riley FBR	Buy
2018-01-18	Reiterato	B. Riley FBR, Inc.	Buy
2017-12-28	Reiterato	B. Riley FBR, Inc.	Buy
2017-12-04	Aggiornamento	Janney	Neutral → Buy
2017-11-08	Aggiornamento	Stifel	Hold → Buy
2017-10-19	Iniziato	FBR & Co.	Buy
2017-09-19	Downgrade	Stifel	Buy → Hold
2017-07-17	Downgrade	Piper Jaffray	Overweight → Neutral
2017-07-14	Iniziato	Janney	Neutral
2017-06-01	Aggiornamento	Piper Jaffray	Neutral → Overweight
2016-07-18	Downgrade	Northland Capital	Outperform → Market Perform
2016-07-18	Downgrade	Piper Jaffray	Overweight → Neutral
2016-02-08	Aggiornamento	Jefferies	Hold → Buy
2015-11-05	Reiterato	Northland Capital	Outperform
2015-10-28	Iniziato	Northland Capital	Outperform

Mostra tutto

Supernus Pharmaceuticals Inc Borsa (SUPN) Ultime notizie

07:44 AM

Supernus a new buy at BofA on 'underappreciated' CNS assets - MSN

07:44 AM

06:21 AM

Supernus Pharmaceuticals Inc. stock trendline breakdownWeekly Stock Report & Momentum Based Trading Ideas - newser.com

06:21 AM

05:22 AM

Advanced analytics toolkit walkthrough for Supernus Pharmaceuticals Inc.2025 Price Momentum & Verified Swing Trading Watchlists - newser.com

05:22 AM

05:01 AM

Can Supernus Pharmaceuticals Inc. stock continue upward trendDollar Strength & Fast Entry High Yield Stock Tips - newser.com

05:01 AM

04:10 AM

Top chart patterns to watch in Supernus Pharmaceuticals Inc.2025 Market Trends & High Accuracy Buy Signal Tips - newser.com

04:10 AM

12:53 PM

How to monitor Supernus Pharmaceuticals Inc. with trend dashboardsEarnings Risk Report & Safe Swing Trade Setup Alerts - newser.com

12:53 PM

12:16 PM

Why Supernus Pharmaceuticals Inc. stock remains undervaluedBond Market & AI Forecasted Entry and Exit Points - newser.com

12:16 PM

12:02 PM

Sentiment analysis tools applied to Supernus Pharmaceuticals Inc.Market Growth Summary & Fast Gain Swing Trade Alerts - newser.com

12:02 PM

Oct 30, 2025

Supernus Pharmaceuticals Hits New 52-Week High of $55.95 - Markets Mojo

Oct 30, 2025

Long term hold vs stop loss in Supernus Pharmaceuticals Inc.IPO Watch & Risk Controlled Swing Alerts - newser.com

Oct 30, 2025

Oct 29, 2025

What institutional flow reveals about Supernus Pharmaceuticals Inc.Treasury Yields & Community Verified Trade Alerts - newser.com

Oct 29, 2025

Supernus Pharmaceuticals Inc Stock Analysis and ForecastQuarterly Earnings Review & Rapid Portfolio Appreciation - earlytimes.in

Oct 29, 2025

Supernus Pharmaceuticals (SUPN) Gains Market Attention with Key CNS Drugs - GuruFocus

Oct 29, 2025

Here's Why Supernus Pharmaceuticals (SUPN) is a Great Momentum Stock to Buy - sharewise.com

Oct 29, 2025

Can Supernus Pharmaceuticals Sustain Momentum After 13% Jump on Neuroscience Pipeline News? - Yahoo Finance

Oct 29, 2025

Supernus Pharmaceuticals Hits New 52-Week High of $53.28 - Markets Mojo

Oct 29, 2025

BofA Securities Initiates Supernus Pharmaceuticals at Buy With $65 Price Target - MarketScreener

Oct 29, 2025

B of A Securities Initiates Coverage on SUPN with a Buy Rating | - GuruFocus

Oct 29, 2025

Supernus Pharmaceuticals (SUPN) Price Target Increased by 32.88% to 59.36 - Nasdaq

Oct 29, 2025

B of A Securities Initiates Coverage of Supernus Pharmaceuticals (SUPN) with Buy Recommendation - Nasdaq

Oct 29, 2025

Is Supernus Pharmaceuticals Inc. stock near bottom after decline2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com

Oct 29, 2025

Using data models to predict Supernus Pharmaceuticals Inc. stock movementTrade Analysis Summary & Safe Entry Trade Reports - newser.com

Oct 29, 2025

It’s Clear How Big Money Flows Lift Supernus - Yahoo Finance

Oct 29, 2025

Oct 28, 2025

Will Supernus Pharmaceuticals Inc. stock gain from lower inflationJuly 2025 Selloffs & Safe Entry Point Alerts - Fundação Cultural do Pará

Oct 28, 2025

Earnings Preview: Supernus Pharmaceuticals (SUPN) Q3 Earnings Expected to Decline - sharewise.com

Oct 28, 2025

Is Supernus Pharmaceuticals Inc. stock supported by strong fundamentalsWeekly Investment Summary & Smart Swing Trading Alerts - Fundação Cultural do Pará

Oct 28, 2025

Oct 27, 2025

Is Supernus Pharmaceuticals Inc. stock attractive after correctionEntry Point & Low Drawdown Trading Strategies - newser.com

Oct 27, 2025